#CML treatment at affordable cost

[lisaoshiola]

We uncover surprising and little-known facts about Chronic Myeloid Leukemia, helping you understand how it can impact your health and what steps you can take to manage it.

[curenishant]

A leukemia diagnosis is life-changing. Beyond the physical

Challenges, patients and their families often face emotional strain and financial burdens. Finding the right place for treatment is critical, as it can determine the success of recovery and the quality of life after treatment. CureIndia has become a trusted partner for patients seeking top-quality leukemia care in India. With its network of world-class hospitals and expert oncologists, CureIndia offers advanced treatments, compassionate support, and affordable healthcare tailored to each patient’s needs.

Expert Care for Complex Conditions Leukemia is a complex cancer that affects the blood and bone marrow. Treating it requires highly specialized knowledge and advanced medical infrastructure. CureIndia collaborates with some of the best hospitals in India, which are equipped with state-of-the-art facilities and staffed by leading oncologists. These experts specialize in treating all types of leukemia, including acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL), chronic myeloid leukemia (CML), and chronic lymphocytic leukemia (CLL).

Our partner hospitals offer a range of cutting-edge treatments such as chemotherapy, targeted therapies, immunotherapy, and stem cell transplants. These methods provide patients with the best chances of remission and long-term recovery. With CureIndia, patients gain access to personalized treatment plans that account for their unique medical history, ensuring that care is tailored to their specific needs.

Affordable Treatment Without Compromising Quality One of the biggest barriers to leukemia treatment in many parts of the world is its high cost. In countries like the USA or UK, leukemia treatment often costs tens of thousands of dollars, creating financial stress for many families. CureIndia provides a solution by offering access to the same high-quality care at significantly lower costs.

India has emerged as a global leader in affordable healthcare without compromising on quality. The hospitals CureIndia partners with are accredited by international bodies such as JCI and NABH, ensuring adherence to the highest medical standards. Patients receive the same advanced treatments they would in Western countries but at a fraction of the cost. This affordability, combined with exceptional medical care, makes India a preferred destination for leukemia treatment.

Personalized Support Every Step of the Way At CureIndia, we believe that healing involves more than just medical treatment—it’s about addressing the emotional and logistical challenges that come with a serious illness like leukemia. From the moment patients reach out to us, our compassionate team provides personalized support. We guide patients through every step of their journey, ensuring they feel informed, empowered, and cared for.

We manage all aspects of treatment planning, from booking consultations with top oncologists to arranging accommodations and travel. For patients traveling with family, we offer assistance with finding comfortable lodging and providing transportation services. Our dedicated team is available around the clock to answer questions and provide reassurance, so patients can focus on what truly matters—getting better.

Simplifying Medical Travel for International Patients For international patients, seeking leukemia treatment abroad can feel overwhelming. From securing visas to understanding local healthcare systems, the process involves numerous steps that can add stress to an already difficult time. CureIndia simplifies medical travel, making the experience as seamless as possible for patients and their families.

Our team handles visa arrangements, airport pickups, and local transportation to ensure patients arrive at their treatment centers without any hassles. We also assist with finding accommodations that suit each family’s preferences and budget. For those who don’t speak the local language, we provide interpretation services, making communication with doctors and medical staff easy and stress-free. CureIndia ensures that patients feel comfortable and supported throughout their stay in India.

Comprehensive Post-Treatment Care The journey to recovery doesn’t end with the final round of chemotherapy or a successful stem cell transplant. Long-term remission and overall well-being depend on post-treatment care, which includes regular monitoring, follow-up consultations, and lifestyle adjustments. CureIndia understands the importance of this phase and provides ongoing support to its patients.

Even after patients return to their home countries, we stay connected with them through virtual consultations with Indian specialists. We coordinate with local doctors to ensure a smooth transition of care. Our holistic approach includes dietary advice, physical rehabilitation, and emotional support to help patients rebuild their strength and maintain a good quality of life. By addressing the needs of patients beyond the hospital, we aim to ensure long-lasting recovery and peace of mind.

Conclusion CureIndia is more than just a medical tourism facilitator—it’s a trusted partner in healing. By connecting patients with India’s best oncologists and hospitals, we ensure access to advanced leukemia treatments at an affordable cost. Our focus on personalized care, seamless medical travel, and comprehensive post-treatment support sets us apart, making us the preferred choice for patients from around the world.

If you or a loved one is battling leukemia, CureIndia is here to guide you every step of the way. With our compassionate team, cutting-edge treatments, and patient-first approach, we help turn the daunting journey of leukemia treatment into a hopeful path toward recovery. Let us be your partner in reclaiming health and building a brighter future.

[bmtclinic]

Leukemia Treatment at BMT Clinic: World-Class Care at Affordable Costs

Leukemia, a type of cancer affecting blood cells, requires specialized treatment to manage and, ideally, achieve remission. The journey through leukemia treatment can be daunting, both physically and emotionally, for patients and their families. Understanding the complexity of the disease and its treatment options, BMT Clinic in India stands at the forefront of leukemia care at , providing world-class treatment at significantly leukemia treatment cost in India is very low compared to Western countries. With our team of leading experts in bone marrow transplantation and a patient-centered approach, we ensure that every patient receives comprehensive care tailored to their unique needs. Understanding Leukemia Leukemia is a cancer of the blood and bone marrow, where the body produces an excessive amount of abnormal white blood cells. These cells crowd out healthy cells, affecting the blood's ability to function properly. There are different types of leukemia, such as acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), chronic lymphocytic leukemia (CLL), and chronic myeloid leukemia (CML). Treatment varies depending on the type and stage of leukemia but often includes chemotherapy, targeted therapy, radiation therapy, and in some cases, bone marrow or stem cell transplantation.

At BMT Clinic, we specialize in cutting-edge treatments for all types of leukemia, with a particular focus on bone marrow transplantation (BMT) — one of the most effective therapies for patients with advanced or high-risk forms of the disease. Services and Treatment Offered at BMT Clinic BMT Clinic is known for its comprehensive leukemia treatment services, particularly its expertise in bone marrow and stem cell transplantation. Our services include: Diagnosis and Initial Consultation The first step in leukemia treatment is an accurate diagnosis. At BMT Clinic, we use advanced diagnostic tools, including blood tests, bone marrow biopsies, and genetic testing, to determine the type and stage of leukemia. Our specialists then create personalized treatment plans tailored to the patient’s condition, taking into account factors such as age, health status, and the specific characteristics of their leukemia.

Chemotherapy Chemotherapy remains one of the primary treatments for leukemia. It involves using drugs to destroy cancer cells and prevent them from multiplying. Depending on the type of leukemia, chemotherapy can be given as an initial treatment to induce remission or as part of a pre-transplant conditioning regimen. At BMT Clinic, we offer both inpatient and outpatient chemotherapy services, ensuring that patients receive the appropriate care in a comfortable and supportive environment. Targeted Therapy For certain types of leukemia, such as chronic myeloid leukemia (CML), targeted therapies have revolutionized treatment outcomes. These drugs, such as tyrosine kinase inhibitors (TKIs), target specific proteins or mutations driving cancer growth, offering more effective and less toxic treatment options compared to traditional chemotherapy. Our specialists at BMT Clinic are well-versed in the latest targeted therapies and will incorporate them into the patient’s treatment plan when appropriate.

Immunotherapy Immunotherapy is an emerging treatment option for leukemia, helping the patient’s immune system recognize and attack cancer cells more effectively. This therapy includes monoclonal antibodies, CAR T-cell therapy, and immune checkpoint inhibitors. At BMT Clinic, we stay up-to-date on the latest advancements in immunotherapy and collaborate with global experts to provide patients with cutting-edge treatment options when applicable. Bone Marrow Transplantation (BMT) Bone marrow transplantation, also known as stem cell transplantation, is one of the most effective treatments for patients with high-risk or relapsed leukemia. This procedure involves replacing the patient’s diseased bone marrow with healthy stem cells, which can regenerate the body’s blood and immune system. BMT Clinic is a leader in bone marrow transplantation in India, offering both allogeneic (donor) and autologous (self) transplants.

Allogeneic Transplant: In this type of transplant, the patient receives healthy stem cells from a donor, which can be a relative or an unrelated, matched donor. The new stem cells help to rebuild the patient’s bone marrow and immune system.

Autologous Transplant: In autologous transplants, the patient’s own healthy stem cells are collected before undergoing intensive chemotherapy or radiation therapy. These stem cells are then reintroduced into the patient’s body to help regenerate the bone marrow after treatment.

Our bone marrow transplant unit is equipped with state-of-the-art technology, and our expert team of transplant specialists ensures that patients receive the highest standard of care before, during, and after the transplant procedure.

Post-Transplant Care and Rehabilitation After a successful bone marrow transplant, patients require close monitoring and supportive care to manage potential complications, such as graft-versus-host disease (GVHD) and infections. At BMT Clinic, we provide comprehensive post-transplant care, including regular follow-up visits, medications, and rehabilitation services to help patients regain their strength and quality of life.

Supportive Care and Counseling Leukemia treatment can be physically and emotionally challenging. At BMT Clinic, we believe in a holistic approach to care, which includes psychological counseling, nutritional support, and pain management. Our multidisciplinary team of doctors, nurses, and counselors work together to address the unique needs of each patient, ensuring they receive not only medical treatment but also emotional and psychological support throughout their journey.

Affordable Treatment Costs at BMT Clinic India has become a leading destination for affordable, high-quality healthcare, and BMT Clinic is at the forefront of providing world-class leukemia treatment at a fraction of the cost compared to countries like the U.S. or the U.K. The cost of leukemia treatment, including bone marrow transplantation, can be prohibitively expensive in many Western countries, often reaching hundreds of thousands of dollars. At BMT Clinic, we offer the same level of care, technology, and expertise at a significantly lower cost, making life-saving treatment accessible to patients from around the world. Chemotherapy Cost: The cost of chemotherapy for leukemia in India is much more affordable, ranging from INR 1,50,000 to INR 3,00,000 ($2,000 to $4,000), depending on the type and duration of treatment.

Bone Marrow Transplantation Cost: The cost of a bone marrow transplant at BMT Clinic is considerably lower than in Western countries. An allogeneic transplant, which may cost over $150,000 in the U.S., can be done at BMT Clinic for around INR 10,00,000 to INR 20,00,000 ($12,000 to $25,000).

In addition to the lower treatment costs, BMT Clinic offers a range of services for international patients, including assistance with medical visas, travel arrangements, accommodation, and post-treatment follow-up care, ensuring a seamless and stress-free experience for patients and their families. Why Choose BMT Clinic? World-Class Expertise: Our team of hematologists, oncologists, and bone marrow transplant specialists are highly experienced in treating all types of leukemia, using the latest medical advancements to improve outcomes.

Personalized Treatment Plans: Every patient is unique, and so is their leukemia. We design individualized treatment plans that are tailored to the patient’s specific type and stage of leukemia, ensuring the best possible outcome. Cutting-Edge Technology: From state-of-the-art diagnostic tools to advanced bone marrow transplantation facilities, we use the latest technology to provide world-class care.

Affordable Costs: At BMT Clinic, we are committed to providing high-quality leukemia treatment at a fraction of the cost compared to other countries, making life-saving care accessible to more patients. Comprehensive Support: From diagnosis through treatment and recovery, our team is dedicated to providing compassionate, holistic care that addresses the physical, emotional, and psychological needs of our patients.

Conclusion At BMT Clinic, we are proud to offer world-class leukemia treatment cost in India at an affordable . Our personalized approach, expert team, and cutting-edge technology ensure that every patient receives the best possible care. Whether you are seeking chemotherapy, targeted therapy, or bone marrow transplantation, BMT Clinic is your trusted partner in the fight against leukemia.

[forerunnershealthcareconsultants]

In this video, we cover information about Chronic Myeloid Leukemia Treatment in India - A type of cancer that affects the blood and bone marrow.

📌 Topics Covered: 💡 What is Leukemia? 💡 What is CML? 💡 What are the causes of Leukemia? 💡 What are the symptoms of Leukemia? 💡 Treatments Options available for CML? 💡 What hospital to select for the treatment of CML?

We uncover surprising and little-known facts about Chronic Myeloid Leukemia, helping you understand how it can impact your health and what steps you can take to manage it.

Our expert insights aim to provide you with a comprehensive understanding of Chronic Myeloid Leukemia, from diagnosis to treatment. Whether you suspect you might have CML or are simply curious, this video is packed with essential information.

📌 Why Choose India? 💡 Expert Care: World-renowned oncologists with specialized experience. 💡 Advanced Facilities: Cutting-edge technology and comprehensive treatment plans. 💡 Affordable Costs: High-quality care at a fraction of global prices. 💡 Medical Tourism: Combine top-notch healthcare with an enriching cultural experience.

Explore world-class treatment options and affordable care in India!

Don't forget to like, share, and subscribe for more health-related content!

Contact us: Medical Care & Surgery in India Call & WhatsApp: +91-9860755000, +91-9371136499 Email Us: surgeryindia123@gmail.com

Address: 33-Maples Business Suites, Sector 51, Gurugram, Haryana, Haryana, India 122001

Social Media: / 61562610098718 / medicalcaresurgeryindia

[cmipooja]

Global Dasatinib Drugs Market Is Estimated To Witness High Growth Owing To Increasing Demand for Targeted Cancer Therapies

The global Dasatinib Drugs Market is estimated to be valued at US$ 4.35 billion in 2023 and is expected to exhibit a CAGR of 6.0% over the forecast period (2023-2030), as highlighted in a new report published by Coherent Market Insights. Market Overview: Dasatinib is an oral medication used for the treatment of chronic myeloid leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL). It is classified as a tyrosine kinase inhibitor and works by blocking the action of abnormal proteins that signal the growth of cancer cells. The advantages of dasatinib include its high efficacy in treating CML, ability to target specific cancer cells, and reduced side effects compared to traditional chemotherapy. The increasing incidence of CML and the demand for targeted cancer therapies are driving the growth of the dasatinib drugs market. Market Key Trends: One key trend in the dasatinib drugs market is the growing focus on precision medicine. Precision medicine aims to tailor treatment strategies based on a patient's genetic makeup, lifestyle, and environmental factors. Dasatinib, being a targeted therapy, aligns with the principles of precision medicine by selectively inhibiting specific cancer cells, thereby reducing the likelihood of adverse effects. For example, research studies have identified specific mutations in the BCR-ABL gene, which can affect the response to dasatinib treatment. This trend emphasizes the importance of personalized therapies and molecular testing in optimizing patient outcomes. PEST Analysis: - Political: Government regulations and policies related to drug approvals, intellectual property rights, and reimbursement can significantly impact the availability and affordability of dasatinib drugs. - Economic: The cost-effectiveness of dasatinib drugs compared to other treatment options, as well as healthcare expenditure and insurance coverage, can influence market growth. - Social: The increasing prevalence of cancer, especially CML, and the awareness and acceptance of targeted therapies among patients and healthcare professionals are driving market demand. - Technological: Advances in genetic testing technologies and biomarker identification are enabling the identification of patients who are likely to benefit the most from dasatinib treatment. Key Takeaways: 1: The Global Dasatinib Drugs Market Demand is expected to witness high growth, exhibiting a CAGR of 6.0% over the forecast period, due to increasing demand for targeted cancer therapies. Dasatinib's efficacy in treating CML and its ability to selectively target specific cancer cells position it as a preferred treatment option. 2: In terms of regional analysis, North America is expected to dominate the dasatinib drugs market due to the high prevalence of CML in the region and the well-established healthcare infrastructure. Asia Pacific is projected to be the fastest-growing region, driven by the increasing incidence of CML and the rising adoption of targeted therapies. 3: Key players operating in the global dasatinib drugs market include Bristol-Myers Squibb Company, Novartis International AG, Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Pfizer Inc., Cipla Ltd., Hetero Drugs Limited, Natco Pharma Limited, Dr. Reddy's Laboratories Ltd., and Aurobindo Pharma Ltd. These companies focus on research and development activities to develop innovative therapies and expand their product portfolios.

[zanypaperprince]

The first thing that comes to our mind is, what exactly is leukemia? In Simple language, this is a cancer of the blood and the bone marrow. Our bone marrow produces blood cells. The leukemia may develop due to a problem with production of the blood cells. It normally affects the leukocytesor white blood cells(WBCs).Leukemia most likely to affect the people over 55 years but this is also most common type of cancer in those below 15 years of the age.

Incase you wish to know more about leukemia treatment in India or leukemia treatment best hospitals and doctors in India, Please Contact our Helpline- +91 9818 857545 for immediate assistance.

The Acute leukemia develops in quick time and get to worse condition rapidly, but chronic leukemia gets bad to worse over time. There are many types of leukemia and the best course or plan of treatment and a patient’s chance of survival from blood cancer depends on which type they have.

In this article, we shall provide an overview of leukemia disease, causes and best leukemia treatment options in India.

Causes of Leukemia -

Leukemia disease develops when DNA of developing blood cells specifically of the white cells incurs some damage. Because of this the blood cells grow and start dividing uncontrollably.

The cells which are healthy they die after a particular interval of time and the new cells replace them. These cells which are abnormal do not die at a natural point in their life span. Instead of that they build up and start occupying more space. As your bone marrow produces more cancer cells they start getting overcrowded in the blood preventing the white blood cells (WBCs) from growth and function normally.

Types of Leukemia -

There are 4 main categories of leukemia:

Acute

Chronic

Lymphocytic

Myelogenous

Acute lymphocytic leukemia -

Children below 5 years of the age are at highest risk of developing this acute lymphoblastic leukemia (ALL). However, this can also affect adults, mostly over 50+ years. A data suggest that out of every 5 deaths from ALL, 4 occur in adults.

Chronic lymphocytic leukemia -

This is common amongst the adults above 55 years of the age, however, younger adults may also develop it. About twenty five percent of adults with leukemia have CLL(chronic lymphocytic leukemia). It is more common in males than in females and very rarely affects the children.

Acute Myeloid leukemia/ Acute Myelogenous Leukemia / Acute Myeloblastic leukemia:

AML is common in adults than in small kids, but if you see overall it is rare type of cancer. It develops more often in males than in females. This develops quickly and symptoms some of the symptoms include difficulty in breathing and pain in the bone joints. The environmental factors (Climate change)can trigger this type.

Chronic Myeloid leukemia:

Chronic myelogenous leukemia (CML) or Chronic Myeloid leukemia mostly develops in the adults. About fifteen % of all leukemia cases in the USA are CML. Children very rarely develop this type of the leukemia disease.

Symptoms of Leukemia -

                 Below mentioned are the treatments given to leukemia patients:

Chemotherapy                                                        

Targeted Therapy

Radiation Therapy

Stem Cell Transplantation

Incase you wish to enquire more about leukemia treatment in India or best leukemia hospitals and specialists in India, Please Contact our Helpline: +91 9818857545 for immediate assistance.

Services offered to Leukemia Patients :

Medical Opinion from the best blood cancer Specialists in India

Medical Visa Assistance

Complete guidance during the planning phase

Airport Transfers  (Airport pickup & Drop)

Logistics Support

Dedicated Case Manager during your treatment in India

Follow up services after departure

GHN Advantages –

Free Medical Opinion from Best Surgeons/Doctors in India upon receipt of Medical reports.

Most Affordable Treatment Packages for your Treatment.

Quick Medical Visa Assistance / Complimentary Airport Transfers.

Dedicated Case Managers for your assistance at the Hospital.

“No Extra Cost”, All Payments directly to the Hospital by cash, Visa card & Wire Transfer etc.

Continuous Follow Up with Cardiac Expert after your Departure from India.

Please share all medical reports of the Patient, You can share them over Our Email- care@ghnservices.com by scanning and sending the Reports or you may choose to whatsApp pictures of reports over +91 9818857545 for Best Leukemia treatment in India.

Related Articles -

Sickle Cell Anemia treatment in India

Cheapest Bone marrow transplant in India

About Stem Cell Transplant in India

Multiple myeloma treatment in India

Our Doctors for Leukemia Treatment in India -

                                          Dr. Dharma Choudhary              Dr. Anil Aribandi                   Dr. Pawan Kumar

Our Testimonials

[ccp30-blog]

Finding Affordable Tasigna Cost: Expectations vs. Reality

What is Tasigna?

Tasigna (Generic Name: Nilotinib) is a drug used for treating of certain critical diseases. It is manufactured / marketed by NOVARTIS and sold internationally. Novartis holds seven patents on this drug thereby preventing this drug to be manufactured as a generic drug by any company worldwide.

Tasigna is generally prescribed to stop or slow down the growth of cancer cells in the body. Its primary purpose is to treat Chronic Myeloid Leukaemia (blood cancer) or CML that is diagnosed Philadelphia chromosome positive. Clinical trials are ongoing and investigation show favourable results in the usage of this Nilotinib in low dosage in the treatment of Alzheimer's disease and Parkinson's disease and also for Huntington's disease, ALS and Dementia.

Side effects of Tasigna / Nilotinib?

If you notice any signs of an allergic reaction such as swelling on your face, lips, tongue and/or throat and difficulty breathing, seek immediate medical attention. If you have heart problems and experience symptoms such as dizziness and/or fast heartbeats, consult your doctor immediately. Additionally, consult your doctor immediately if you experience any of the following symptoms:

•limited blood flow, signs: numbness, trouble walking, leg pain, chest pain or problems in speaking

•tumour cell breakdown, signs: nausea, vomiting, change in heart rate (above or below the average beats per minute), tingling in hands, feet and mouth, muscle cramps and/or confusion

•unusual bleeding in urine, stool or bruises

•rapid weight gain or swelling

•low blood cell counts, signs: mouth sores, pale skin, unusual weakness & chills, night sweats and/or fever

•internal bleeding in the brain, signs: confusion, difficulty in seeing, headaches and/or dizziness

 Some of the other more common side effects include:

•rashes and sudden hair loss

•night sweats and tiredness

•joint pains

•headaches

•constant sneezing with a running nose

•constant coughing with a sore throat

Tasigna can also affect a child's growth. If your child is not growing at a normal rate while on this medicine, consult your doctor immediately.

The above list does not include all the side effects of Nilotinib, consult your doctor to find out more about any other probable side effects.

Expectation Vs Reality: How to be sure that the drug and service is authentic?

The first and the most basic check is to see if the seller of the drugs has displayed their physical address or is hiding see if the seller of the drugs has displayed their physical address or is hiding behind some "fill-up-a-form-contact-us" curtain. Normal logic says that if they are hiding their address, they have much to hide about their drugs too – Genuine or Fake is your decision.

Secondly, the FDA - The Food and Drug Administration – of almost all the countries require the FDA License Number, the batch number, expiry date and manufacturer's address to be printed on both the primary drug pack as well as the secondary outer package. Check if all these details are mentioned on the drug packs as this is by far the best check to know if the drug is authentic, as authorized for manufacture by that FDA, or is illegal or fake.

Lastly, visual inspection as stated by the World Health Organization (WHO) (1999) is also a good benchmark in identifying potential fake drug irrespective of the analytical methods used. This is because such observation serves as a lead to identifying fake products even in the absence of the knowledge of the physical characteristics of a genuine drug product.

As stated by WHO, commonly encountered physical defects that should be looked out for in tablets include:

a. Excessive powder and/or pieces of tablets at the bottom of the container (from abraded, crushed or broken tablets); b. Cracks or chips in the tablets, swelling, mottling, discolouration, fusion of tablets; c. Appearance of crystal on the walls of the container or on the tablet. d. Hardening or softening, cracking, swelling, mottling or discolouration of capsule shell should also be looked out for.

These are some of the factors which should satisfy you on all our drugs being authentic. Your trust in us to make the first purchase will practically prove that we source and deliver only authentic drugs from licensed international pharmacies and manufacturers located in Australia, Canada, EU, India, New Zealand, Singapore, Switzerland, USA and many reputable countries.

All of the medicines that we sell are approved by the FDA which requires the FDA license number, batch number, expiry date and manufacturer's to be printed on the primary drug packaging as well as the outside secondary outer packaging.

How can I buy Tasigna?

You can purchase Tasigna / Nilotinib by any of the following ways:

1.       Order Online

·         Visit the website https://www.cancercurepharmacy.com

·         Visit the Tasigna product page through the search field or product category tab.

·         Select you required dosage and pack size of Tasigna and click “Buy Now” to add it to your shopping cart.

·         Once the required quantity has been selected you would be redirected to the Cart, you will then be guided through the account creation check-out process of the website

·         Upon receiving the order invoice, you can send the prescription at customercare@cancercurepharmacy.com

 2.       Order by Phone

·         Browse our website to view the prices of Tasigna / Nilotinib.

·         We follow the principles of inbound strategy for customer service and understand the importance & reassurance of speaking with a live person.

·         Our patient care specialists are available from Monday to Saturday from 1:30 pm to 5 pm Hong Kong Standard Time (GMT +8).

 3.       Order by Mail

·         Browse our website to view the prices of Tasigna / Nilotinib.

·         Write to us at customercare@cancercurepharmacy.com so we can place the order from your behalf

·         Please make sure to include the following details:

o   Name, Full Address with Zip Code and the Mobile Contact No. of the person to whom Tasigna / Nilotinib is to be shipped

o   A copy of your doctor’s prescription

How to find the best online medication store?

                        On every search result, you are likely to come across several online pharmacies that sell medications for treating cancer with different price ranges. But a key query that arises in most of the users is whether the online pharmacy they visit is genuine or not.

You can follow some of these tips to be certain of a business’s legitimacy:

·         Visit their website to read any reviews/testimonials by their customers

·         Find the physical address of their branch or corporate office

·         Ask for their business registration number

·         Ask for a reference by one of their customers in your region

·         Are there any hidden charges levied upon placing the order

Some Important Links: -

Tasigna Cost, Tasigna Generic

https://www.cancercurepharmacy.com/Testimonials.aspx 

https://www.cancercurepharmacy.com/WhyGenerics.aspx

https://www.cancercurepharmacy.com/FAQ.aspx

https://www.cancercurepharmacy.com/Anti-Cancer-Drugs@76-Generic-of-Brand-Tasigna-Nilotinib-buy-at-Lowest-Cheapest-High-Discount-Price.aspx 

[specialty-online-pharmacy]

Natco Pharmaceuticals is a R&D focused player with strong focus on oncology and hepatology. Natco pioneered the launch of several generic versions of drugs in the domestic oncology segment and holds a leading position in their operated portfolios. Veenat, a generic version of Swiss multinational Novartis AG’s anticancer drug Gleevec, is one of the key products that are produced by Natco Pharma in India. This medicine is available in 2 dosage form :

Veenat 400 mg Tablets

    2. Veenat 100 mg Capsules

Treatment with Veenat (Imatinib) results in good overall survival (OS) in patients with chronic myeloid leukemia (CML), approaching a normal life expectancy, according to the long-term follow-up of the CML-IV study. Veenat has also led to significant increases in survival in patients with -

• Progressive Gastrointestinal Stromal Tumors GIST, • Acute Lymphoblastic Leukemia, • Myelodysplastic/Myeloproliferative Diseases, • Hypereosinophilic Syndrome/Eosinophilic Leukemia and • Dermatofibrosarcoma Protuberans

Availability of Veenat (Imatinib) has dramatically changed the outlook of patients which are suffering with CML and other types of blood cancer. The response was identical for those treated with innovator brand of imatinib as compared to the generic brand. Hence quality generics provide a cost effective solution, which is particularly relevant in the current global scenario. Veenat is 1/10 low price compare of its USA brand name Glivec/Gleevec. The lowest price of Veenat improves access to medicines in low-and middle-income countries.

Drugssquare.com - Online Supplier of Generic & Branded Medicines

The pharmaceutical sector is one of the most prominent sectors today and owing to the increasing demand for drugs and medicines, the sector is scaling new heights with each passing day. We, at Drugssquare.com, are completely devoted to the motto of providing high quality, affordable and innovative medicines solutions as per customer's choice and requirement. We hold a reputed name when it comes to generic medicines and branded medicines. For more information regarding our generic medicine supplying in several parts of International market, you can call @ +91-7777881188 or email : info@drugssquare.com

[isaacscrawford]

What Does an Ideal Healthcare System Look Like?

By ASHISH JHA, MD

Austin Frakt and Aaron Carroll recently approached me about a New York Times UpShot piece aiming to rank eight healthcare systems they had chosen: Australia, Canada, France, Germany, Singapore, Switzerland, the United Kingdom, and the United States. This forced me to think about a pretty fundamental question: what do we want from a healthcare system?

I would argue that most people want a healthcare system where they can get timely access to high quality, affordable care and one that also promotes innovation of new tests and treatments. But underlying these sentiments are a lot of important issues that need unpacking. First, what does it mean to be able to access care when you need it? A simple way to think about this is being able to see a doctor (or other healthcare professional) quickly and easily and in cases where there are follow-on tests, procedures, and treatments, you can get them without much delay. This brings up one important point: while experts often discount the importance of timeliness, regular people generally don’t: anyone who has waited weeks or months for a follow-up after an abnormal test result or to get a needed surgery knows that waiting times are not just an inconvenience. Delayed access can be stressful, agonizing and in some instances, downright harmful.

Beyond access, of course, we want care we can afford. Almost all of us need some sort of insurance that would pay for an unexpected, catastrophic healthcare expense (like spending a few weeks in an ICU). Most of us need some sort of financial coverage for other, slightly less expensive services such as an MRI or a knee replacement. And even still, some of us will struggle to pay for simpler things like doctors’ visits and need financial help there as well.  There is broad consensus that we want a healthcare system where people aren’t denied the services they need because they can’t afford them.

While accessibility, timeliness, and affordability are key, there are other aspects of care that get less attention but are just as important: we want care that is safe and effective and produces the best outcomes possible.  It’s great if you can have timely cardiac surgery and pay little or nothing out of pocket. But if you die unnecessarily from a preventable error, you didn’t get what you needed from the healthcare system.

Finally, we want a healthcare system that creates new knowledge so that we get better at caring for sick people. One of my earliest memories of medical school was caring for a young woman, an artist with two small children, who died of a complication of chronic myelogenous leukemia after a bone marrow transplant. Today, her disease could have been managed by a simple, daily pill that has turned CML into a chronic, yet manageable disease.  A system that generates new therapies that save lives is critical and its importance is often overlooked when assessing health system performance.

Health System Organization

So what is the ideal way to organize a healthcare system to accomplish these goals? One school of thought believes that market-based systems are the solution because they rely on competition, customize care for individuals, keep prices down, and allow the highest quality providers to flourish. For others, the answer is a government-run, single-payer system where everyone has equal access, gets comparable quality, and patients don’t have to worry about costs because the government takes care of it. While either approach can be supported with selected data and facts, as I have looked at health systems from around the globe, one theme becomes obvious: systems organized very differently can achieve comparable levels of performance and no single approach consistently outperforms others.

So which countries have the best systems? As the UpShot piece outlines, we did a tournament-style competition where in each round, we had to pick winners and losers.  At the end, we were also asked to rank the selected 8 countries based on our overall assessment. To do so, my approach was simple. Health systems should be judged not by how they are organized (i.e. markets or government) but what they produce. How well does it do what a healthcare system ought to do? So that’s the approach I took.

Evaluating Health Systems

That leads us to the next question: what metrics should we use? If you made it to the first day of a health policy 101 class, you learned about two metrics: per capita spending and life expectancy.  If you made it to the second  class, you learned that unfortunately, these are far too crude to tell you much about health system performance and do not help generate an actionable set of policy prescriptions.  Health care spending is driven by many factors, including what is encompassed in spending calculations (research and development? medical education?) and prices (if one country pays its nurses half as much as another – does that mean the first is twice as efficient?).  Life expectancy is even more complicated as it is driven in large part by behavior, lifestyle, and genetics of the underlying population. As Irene Papanicolas and I point out in our recent JAMA piece, drawing these boundaries when comparing healthcare systems is important.

So if we can’t just look at those metrics, what else should we examine? While one could evaluate literally hundreds of metrics, I prioritized 16 (see Table 1).

None of these are perfect but they seemed reasonable to me – a few on access, quality, cost and innovation. Ultimately, I was interested in assessing performance in areas that are clearly within the purview of the healthcare system – how many people are covered and covered for what? How quickly can you see someone when you’re sick? How good is the system at taking care of you when something terrible happens, like you have a stroke or a heart attack? Does the system generate lots of innovation so that everyone’s care gets better over the time?  I tried not to overly weigh any one of these but tried to look at them holistically.

My Rankings

Based on these measures (for country data, see Table 2), my ranking of the selected health systems is as follows:

Switzerland

Germany

U.S.A.

U.K.

France

Australia

Canada

Singapore

A few caveats.  First, these are all very good healthcare systems – and we’re generally comparing systems that are far superior to much of the rest of the world. Second, there was rarely a clear winner in head to head competitions.  Switzerland and Germany both have excellent systems and reasonable people could draw a different conclusion from the same data. I struggled among the U.S., France, Australia, and the U.K., all of which had clear strengths and clear challenges. Singapore lagged behind in large part because there is so little data about their performance and lack of data means it might be better than it looks, or it could be worse. I just don’t know.

The ranking of the U.S. above places like France and the UK may be surprising. Some people will point, rightly, to the fact that the U.S. has the highest spending in the world yet still has people who are uninsured. The healthcare spending problem of the U.S. is largely a political choice – we have extraordinarily high prices on everything from physician salaries to pharmaceuticals.  While some of these high prices may spur innovation (i.e. pharmaceuticals), the cost of spending nearly 20% of our GDP on healthcare means less money for everything else. We could do better with different policy choices.

On the issue of universal coverage, things are a bit more complicated. While its narrowly true that the U.S. is the only country here without universal coverage, it’s too simplistic.  First, 91% of Americans are now insured (thanks in part to the ACA).  Some countries have universal coverage for their citizens but not necessarily for immigrants or other groups. Second, it is important to consider what is actually covered.  While most Americans can get access to the latest treatments, in many countries, access to the most expensive therapies can be difficult or non-existent.  I don’t know if we will get to 100% coverage but we are inching towards it and I hope that with the next set of policy reforms, we can get into the high 90’s.  And that would be good.

Finally, if you take a big step back and look at the data, Americans do better than average in timely access, especially to specialty services and “elective” surgery (which is often not that elective).  They tend to be among the leaders in acute care quality, when healthcare means the difference between life and death, although the quality of primary care could surely be better.  And America is the innovation engine of the world, pumping out new drugs and treatments that benefit the whole world.  All of that earns America a high rank in my book – behind Switzerland and Germany but ahead of others. You can disagree but overall, while the U.S. healthcare system has a lot of work ahead, we should not overlook its strengths – and they are sizeable.

So here’s the big picture: when it comes time to measure health system performance, it’s important to think about boundaries (what is the responsibility of the healthcare system and what isn’t).  It’s also important to consider whether the system is delivering what people need: coverage of a broad range of services, especially those that are important for the sickest among us, timely access to affordable, high quality care, and innovation that ensures care gets better over time.  For most people, whether the system is market-based or government-run matters a lot less than whether it’s meeting their needs. And that’s the way it should be.

Article source:The Health Care Blog